TERMIS 2021 | Barriers to tissue engineering research in academia

Małgorzata Lewandowska-Szumieł, PhD, Medical University of Warsaw, Warsaw, Poland, discusses problems academics face in the field of tissue engineering. As tissue engineering products are classed as medicinal products, research laboratories must face increased regulations and adhere to good manufacturing practice (GMP) guidelines, increasing costs. Prof. Lewandowska-Szumieł additionally highlights the need for specialized research grants and describes her experiences in conducting clinical trials investigating adipose-derived stem cells in healing foot ulcers. This interview took place at the 6th World Congress of the Tissue Engineering and Regenerative Medicine International Society (TERMIS 2021).